AbbVie’s (No. 12 on the 2024 Top 50 Companies list) 2023 ESG Action Report underscores the company’s commitment to innovation and serving its patients. This comprehensive report details AbbVie’s progress in Environmental, Social and Governance (ESG) initiatives. Additionally, it highlights the company’s efforts to create a sustainable and inclusive future. Key achievements include:
- Spent over $1 billion working with small businesses in the United States and Puerto Rico.
- More that 218,000 patients gained access to medicine at no cost through AbbVie’s patient assistance programs.
- Achieved an 81% employee engagement rate, according to the company’s 2023 Employee Survey.
- Saw a 29% reduction in hazardous and non-hazardous waste production. This achievement exceeded its initial goal of a 20% reduction from the levels recorded in 2015.
In a press release, AbbVie Chairman and CEO Richard A. Gonzalez said the company “continued to take meaningful actions that delivered sustainable solutions for our business and society” in 2023.
“Our current pipeline of approximately 90 active clinical and device programs reflects our commitment to helping patients for generations to come and is critical to sustaining our future growth,” he said. “We continue to increase our investment in R&D to record levels and to pursue business Compounds, devices or indications in development individually or under collaboration or license agreements.”
Click here to view the full 2023 ESG Action Report.
